Article: Geron to Present at 4 Upcoming Investor Conferences.(Conference news)

Geron Corp. announced that the company will present updates of its product development programs at four investor conferences in the month of September.

In a release, the Company noted event details:

Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice president and chief medical officer for oncology, will review Geron's portfolio of anti-cancer therapies, including its telomerase inhibitor drug (imetelstat - GRN163L) and its telomerase therapeutic vaccine (GRNVAC1) at the following conference:

- Rodman & Renshaw 11th Annual Healthcare Conference in New York, at 9:35 am ET on Thursday, September 10.

Thomas B. Okarma, Ph.D., ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!